Fluoxetine affords QOL benefit in advanced cancer, depression

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.416, 2003-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fluoxetine plus therapy boosts QOL in depression

Inpharma, Vol. 1, Iss. 1573, 2007-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Sertraline, fluoxetine, paroxetine: similar QOL in depression

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 345, 2002-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Sertraline, fluoxetine, paroxetine: similar QOL in depression

Inpharma, Vol. 1, Iss. 1320, 2002-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Depression, anxiety and poor QOL in women with ovarian cancer

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 286, 2000-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Administering eszopiclone at bedtime to patients with depression and insomnia who are being treated with fluoxetine improves their QOL

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 581, 2009-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite